Summit Therapeutics (SMMT) Insider Trading & Ownership $18.60 +1.00 (+5.68%) Closing price 09/11/2025 04:00 PM EasternExtended Trading$19.42 +0.81 (+4.38%) As of 09:19 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Summit Therapeutics (NASDAQ:SMMT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage84.90%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$11.97MNumber OfInsiders Selling(Last 12 Months)0 Get SMMT Insider Trade Alerts Want to know when executives and insiders are buying or selling Summit Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SMMT Insider Buying and Selling by Quarter Summit Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/11/2025Mahkam ZanganehCEOBuy5,000$18.07$90,350.00 9/11/2025Robert W DugganCEOBuy5,000$18.07$90,350.00 9/10/2025Mahkam ZanganehCEOBuy333,394$17.68$5,894,405.92 9/10/2025Robert W DugganCEOBuy333,394$17.68$5,894,405.92 (Data available from 1/1/2013 forward) SMMT Insider Trading Activity - Frequently Asked Questions Who is on Summit Therapeutics' Insider Roster? The list of insiders at Summit Therapeutics includes Ankur Dhingra, Mahkam Zanganeh, Manmeet Singh Soni, and Robert W Duggan. Learn more on insiders at SMMT. What percentage of Summit Therapeutics stock is owned by insiders? 84.90% of Summit Therapeutics stock is owned by insiders. Learn more on SMMT's insider holdings. Which Summit Therapeutics insiders have been buying company stock? The following insiders have purchased SMMT shares in the last 24 months: Ankur Dhingra ($419,268.00), Mahkam Zanganeh ($6,107,605.92), Manmeet Singh Soni ($4,999,999.20), and Robert W Duggan ($5,984,755.92). How much insider buying is happening at Summit Therapeutics? Insiders have purchased a total of 3,808,378 SMMT shares in the last 24 months for a total of $17,511,629.04 bought. Summit Therapeutics Key ExecutivesMr. Robert W. Duggan (Age 80)Co-CEO & Executive Chairman 2 recent tradesDr. Mahkam Zanganeh D.D.S. (Age 54)M.B.A., Co-CEO, President & Director Compensation: $657.81kMr. Manmeet Singh Soni (Age 46)COO, CFO & Director Compensation: $591.5kProf. Dame Kay Davies DBE (Age 73)FRS CBE, Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor Mr. Bhaskar Anand (Age 46)Chief Accounting Officer & Head of Finance Ms. Abby Guzman MurphyHead of Human ResourcesMs. Divya Chari (Age 56)Head of Global Clinical Operations Mr. Dave GancarzChief Business & Strategy OfficerDr. Betty Y. Chang Ph.D.Head of Research, Oncology & InflammationDr. Fong ClowChief Biometrics Officer More Insider Trading Tools from MarketBeat Related Companies MRK Insider Ownership TAK Insider Ownership ARGX Insider Ownership ONC Insider Ownership INSM Insider Ownership BNTX Insider Ownership TEVA Insider Ownership GMAB Insider Ownership VTRS Insider Ownership BBIO Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Sell These High-Quality Stocks: Why Investors Shouldn’tCoreWeave and Madrigal's Insider Trades Flash Bullish SignalsPalantir Insider Selling: Risk Signal or Normal Activity?Loop Industries Insiders Buy Stock, Signal Confidence in OutlookDueling Insider Moves: Heavy Buying Here, Big Selling There This page (NASDAQ:SMMT) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCollege grad makes $64,000 a monthIt's easy to feel like you've missed out on the biggest stock market boom of the century. But if you want t...Stansberry Research | SponsoredUrgent: $3,452.50 a Month in Passive "AI Equity Checks"The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored2013 Bitcoin miner reveals his trading system (free)There are 18,347 cryptocurrencies in the market right now. 99% of them will fail. And trying to pick winner...Crypto Swap Profits | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Summit Therapeutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Summit Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
